Canaan’s ‘accelerating turnaround story’ makes it a buy as Avalon miner orders surge: Benchmark
Quick Take Canaan’s recent 50,000-unit Avalon order and growing self-mining footprint signal stronger positioning in both hardware and operations. Benchmark said its new gas-to-compute pilot in Canada could open a path toward AI and high-performance computing markets.
Canaan (ticker CAN) is ramping up momentum, according to a new note from Benchmark analyst Mark Palmer, who reiterated a "buy" rating and lifted his price target to $4 — more than double the stock’s current level, just under $1.80 according to The Block's price data .
Earlier this month, the company regained compliance with Nasdaq’s $1 minimum bid requirement, removing a potential delisting overhang that had weighed on liquidity and limited institutional participation.
Canaan share price. Source: The Block price page
The firm said Canaan’s “accelerating turnaround story” is being fueled by surging demand for its Avalon A15-series rigs, including a 50,000-unit U.S. order earlier this month that marked the company’s biggest sale since 2022.
Benchmark said Canaan’s progress on the operational front — including its return to Nasdaq compliance, an expanding bitcoin self-mining base, and a record high treasury of 1,582 BTC and 2,830 ETH, worth approximately $184 million at current prices, provides a strong foundation for renewed investor confidence.
The firm also highlighted Canaan’s new gas-to-compute pilot in Alberta, Canada, where it is partnering with Aurora AZ Energy to repurpose stranded natural gas into electricity for bitcoin mining and AI workloads.
“With the Nasdaq overhang resolved and Avalon shipments ramping, Canaan is well positioned to deliver further share-price appreciation,” Palmer wrote.
Canaan's CAN stock is up nearly 5% on the day, trading at $1.79, according to The Block's price page .
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SUI SuperTrend Flips to Buy — Macro Shift From Bearish to Bullish Begins
Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"
After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.
STONK hits new highs after erasing 27% crash
25 Days, Four Launches in Sight! Rocket Lab (RKLB.US) Accelerates Rocket Launches to Advance Its Ambitious "Space AI Infrastructure" Goals
After another successful mission, Rocket Lab's 97th Electron rocket is now positioned at the launch pad. This flight will be Rocket Lab's fourth launch in 25 days and its 18th launch in 2026.
Crypto prices
More
